Akari Therapeutics
Jul 17, 2020
An Eye-Blinding Scenario of Vernal keratoconjunctivitis
The present Vernal keratoconjunctivitis market size in all the markets (the US, EU-5 (Germany, France, Italy, Spain, United Kingdom), Japan, China, MEA (Saudi Arabia, Egypt), and Russia) was estimated to be USD 307.89 million in 2017 and is anticipated to increase further by 2030 owing to recent advances in technol...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
